Wed, April 3, 2024
Tue, April 2, 2024
Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024
Wed, March 27, 2024

Colin Bristow Maintained (ABOS) at Strong Buy with Decreased Target to $14 on, Mar 31st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-14-on-mar-31st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Colin Bristow of UBS, Maintained "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy with Decreased Target from $15 to $14 on, Mar 31st, 2024.

Colin has made no other calls on ABOS in the last 4 months.



There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Colin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Colin


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $15 on, Wednesday, March 27th, 2024
  • Neena Bitritto-Garg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $8 on, Tuesday, December 12th, 2023

Publication Contributing Sources